Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANS-6637 in Alcohol Use Disorder
NCT03970109Phase 2Terminated
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Oct 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ANS-6637 in alcohol use disorder (AUD), sponsored by National Institute on Alcohol Abuse and Alcoholism. Started Oct 2019; status: terminated.
02
Drugs
ANS-6637
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03970109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970109.